
TruBridge Inc (TBRG) Stock Forecast & Price Target
TruBridge Inc (TBRG) Analyst Ratings
Bulls say
TruBridge Inc. has demonstrated a strong financial performance, with Patient Care gross margins increasing to 59.6%, driven by effective cost rationalization and non-recurring revenue, reflecting improved management efficiency. The company's Financial Health segment, which was formerly labeled as RCM, exhibited organic revenue growth of 5% year-over-year, supported by successful offshoring initiatives and operational improvements. Additionally, TruBridge has shown a positive outlook for FY25, raising revenue estimates from $349 million to $353 million, highlighting the company's effective strategies in client acquisition and service delivery.
Bears say
TruBridge Inc. faces significant challenges as evidenced by a substantial decline in bookings, with overall bookings decreasing by 45% year-over-year, and notable drops in both Financial Health and Patient Care segments reporting declines of 40% and over 50% year-over-year, respectively. Additionally, the company's revenue guidance for 1Q25 is projected to be 1% below consensus estimates, suggesting an inability to meet market expectations. Although management expresses optimism regarding potential future deals, the reliance on slipped contracts and external factors introduces heightened investor uncertainty, contributing to a negative outlook on the stock's performance.
This aggregate rating is based on analysts' research of TruBridge Inc and is not a guaranteed prediction by Public.com or investment advice.
TruBridge Inc (TBRG) Analyst Forecast & Price Prediction
Start investing in TruBridge Inc (TBRG)
Order type
Buy in
Order amount
Est. shares
0 shares